Clinical Trials Directory

Trials / Sponsors / Michael Morse, MD

Michael Morse, MD

Academic / Other · 6 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study of Niclosamide in Patients With Resectable Colon Cancer
Colon Cancer
Phase 12017-11-07
CompletedStudy to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Brea
Metastatic Breast Cancer
Phase 1 / Phase 22009-07-01
TerminatedA Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation
Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL)
Phase 12007-06-01
CompletedA Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer
Epithelial Ovarian, Tubal or Peritoneal Cancer
Phase 12007-03-01
CompletedVaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
Colorectal Cancer, Metastatic Cancer
Phase 22005-02-01
CompletedVaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Breast Cancer, Colorectal Cancer, Gallbladder Cancer
Phase 12002-01-01